Two Sigma Investments’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-36,012
| Closed | -$2.44M | – | 4171 |
|
|
2019
Q3 | $2.44M | Sell |
36,012
-180,524
| -83% | -$12.4M | 0.01% | 1271 |
|
|
2019
Q2 | $12.6M | Sell |
216,536
-97,427
| -31% | -$5.77M | 0.04% | 498 |
|
|
2019
Q1 | $22M | Buy |
313,963
+104,371
| +50% | +$7.74M | 0.07% | 359 |
|
|
2018
Q4 | $13.5M | Buy |
209,592
+195,004
| +1,337% | +$13.7M | 0.05% | 449 |
|
|
2018
Q3 | $1.02M | Sell |
14,588
-55,726
| -79% | -$3.26M | ﹤0.01% | 1965 |
|
|
2018
Q2 | $3.54M | Buy |
70,314
+6,276
| +10% | +$249K | 0.01% | 1227 |
|
|
2018
Q1 | $2M | Buy |
64,038
+45,038
| +237% | +$1.49M | 0.01% | 1518 |
|
|
2017
Q4 | $650K | Sell |
19,000
-23,043
| -55% | -$735K | ﹤0.01% | 2258 |
|
|
2017
Q3 | $1.35M | Sell |
42,043
-39,228
| -48% | -$1.24M | ﹤0.01% | 1539 |
|
|
2017
Q2 | $2.65M | Sell |
81,271
-98,329
| -55% | -$3.11M | 0.01% | 1234 |
|
|
2017
Q1 | $5.66M | Sell |
179,600
-26,234
| -13% | -$776K | 0.02% | 875 |
|
|
2016
Q4 | $6.05M | Sell |
205,834
-24,408
| -11% | -$744K | 0.02% | 749 |
|
|
2016
Q3 | $6.66M | Buy |
230,242
+88,777
| +63% | +$2.47M | 0.02% | 739 |
|
|
2016
Q2 | $3.66M | Sell |
141,465
-2,401
| -2% | -$63.8K | 0.02% | 916 |
|
|
2016
Q1 | $3.56M | Buy |
143,866
+16,497
| +13% | +$453K | 0.02% | 866 |
|
|
2015
Q4 | $4.48M | Buy |
127,369
+100,236
| +369% | +$2.68M | 0.02% | 702 |
|
|
2015
Q3 | $574K | Sell |
27,133
-27,353
| -50% | -$705K | ﹤0.01% | 1480 |
|
|
2015
Q2 | $1.51M | Buy |
+54,486
| New | +$1.54M | 0.01% | 1376 |
|
|
2015
Q1 | – | Sell |
-53,661
| Closed | -$1.72M | – | 2974 |
|
|
2014
Q4 | $1.72M | Buy |
53,661
+45,664
| +571% | +$1.49M | 0.01% | 1089 |
|
|
2014
Q3 | $226K | Sell |
7,997
-53,743
| -87% | -$1.5M | ﹤0.01% | 1564 |
|
|
2014
Q2 | $1.69M | Buy |
+61,740
| New | +$1.64M | 0.01% | 1108 |
|
|
2014
Q1 | – | Sell |
-36,963
| Closed | -$1.08M | – | 2390 |
|
|
2013
Q4 | $1.08M | Buy |
+36,963
| New | +$1.17M | 0.01% | 1293 |
|
|
2013
Q3 | – | Sell |
-89,912
| Closed | -$2.85M | – | 2228 |
|
|
2013
Q2 | $2.85M | Buy |
+89,912
| New | +$2.95M | 0.02% | 719 |
|
Two Sigma Investments's GHDX Position: Q4 2019 in Review
Two Sigma Investments sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 36,012 shares — an estimated $2.44M sold.
Two Sigma Investments first reported a position in GHDX in Q2 2013 and held it in 23 quarters. The position peaked at $22M in Q1 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- Two Sigma Investments reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- Two Sigma Investments sold 36,012 Genomic Health, Inc. shares in Q4 2019, an estimated $2.44M.
- Two Sigma Investments first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 23 quarters.
- Two Sigma Investments's Genomic Health, Inc. position peaked at $22M in Q1 2019.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on Two Sigma Investments's 13F filing for Q4 2019, filed 14 Feb 2020.